The company’s computational solution uses AI, modeling and data analysis of naturally occurring proteins to generate superior antibodies, enzymes and vaccine immunogens.
Scala Biodesign launches with $5.5M to develop bioproducts from proteins
The company’s computational solution uses AI, modeling and data analysis of naturally occurring proteins to generate superior antibodies, enzymes and vaccine immunogens.
